Amylin-Based Therapeutics Summit 2026

 

The inaugural Amylin‑Based Therapeutics Summit 2026 is the first and only industry‑dedicated forum bringing biopharma and academia together to dive deep and explore the full breadth of amylin drug development – from foundational receptor biology to late‑stage clinical strategy.

Across two immersive days, learn from and connect with pioneering minds from Novo Nordisk, Eli Lilly, Zealand Pharma, iBio, I2O Therapeutics and emerging innovators who are collectively shaping the field.

Continue reading for the full event guide

 

More Info

---

---